Nephrology Sector Of The Immunology Market: A Major Biopharma Development Opportunity

Pharmaceutical Online - Agatha Wisniowska and Ashwin Singhania, Guidehouse

Read Full Article in Pharmaceutical Online

For pharmaceutical companies seeking their next major opportunity, multiple recent breakthroughs in novel mechanisms of action (MOAs) have set the stage for advances in immunology treatment options. However, analysis identifies one market in particular — nephrology — among the best therapeutic development bets, due to current market conditions and a significant unmet need.

Back to top